These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 12506103

  • 1. Topical nepafenac inhibits ocular neovascularization.
    Takahashi K, Saishin Y, Saishin Y, Mori K, Ando A, Yamamoto S, Oshima Y, Nambu H, Melia MB, Bingaman DP, Campochiaro PA.
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):409-15. PubMed ID: 12506103
    [Abstract] [Full Text] [Related]

  • 2. The effects of nepafenac and amfenac on retinal angiogenesis.
    Yanni SE, Clark ML, Yang R, Bingaman DP, Penn JS.
    Brain Res Bull; 2010 Feb 15; 81(2-3):310-9. PubMed ID: 19897019
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
    Reich SJ, Fosnot J, Kuroki A, Tang W, Yang X, Maguire AM, Bennett J, Tolentino MJ.
    Mol Vis; 2003 May 30; 9():210-6. PubMed ID: 12789138
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model.
    Ayalasomayajula SP, Kompella UB.
    Eur J Pharmacol; 2003 Jan 05; 458(3):283-9. PubMed ID: 12504784
    [Abstract] [Full Text] [Related]

  • 7. Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development.
    Vinores SA, Xiao WH, Aslam S, Shen J, Oshima Y, Nambu H, Liu H, Carmeliet P, Campochiaro PA.
    J Cell Physiol; 2006 Mar 05; 206(3):749-58. PubMed ID: 16245301
    [Abstract] [Full Text] [Related]

  • 8. Combretastatin A-4 phosphate suppresses development and induces regression of choroidal neovascularization.
    Nambu H, Nambu R, Melia M, Campochiaro PA.
    Invest Ophthalmol Vis Sci; 2003 Aug 05; 44(8):3650-5. PubMed ID: 12882819
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on the maintenance of intraoperative mydriasis during cataract surgery: a randomized trial.
    Zanetti FR, Fulco EA, Chaves FR, da Costa Pinto AP, Arieta CE, Lira RP.
    Indian J Ophthalmol; 2012 Jul 05; 60(4):277-81. PubMed ID: 22824596
    [Abstract] [Full Text] [Related]

  • 11. Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac.
    Lindstrom R, Kim T.
    Curr Med Res Opin; 2006 Feb 05; 22(2):397-404. PubMed ID: 16466612
    [Abstract] [Full Text] [Related]

  • 12. Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment.
    Ohno-Matsui K, Hirose A, Yamamoto S, Saikia J, Okamoto N, Gehlbach P, Duh EJ, Hackett S, Chang M, Bok D, Zack DJ, Campochiaro PA.
    Am J Pathol; 2002 Feb 05; 160(2):711-9. PubMed ID: 11839592
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL, Suh W.
    Invest Ophthalmol Vis Sci; 2017 Jul 01; 58(9):3592-3599. PubMed ID: 28715845
    [Abstract] [Full Text] [Related]

  • 15. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
    Inoue Y, Shimazawa M, Nakamura S, Takata S, Hashimoto Y, Izawa H, Masuda T, Tsuruma K, Sakaue T, Nakayama H, Higashiyama S, Hara H.
    Arterioscler Thromb Vasc Biol; 2018 Jan 01; 38(1):174-185. PubMed ID: 29191924
    [Abstract] [Full Text] [Related]

  • 16. AAV-mediated expression of vascular endothelial growth factor induces choroidal neovascularization in rat.
    Wang F, Rendahl KG, Manning WC, Quiroz D, Coyne M, Miller SS.
    Invest Ophthalmol Vis Sci; 2003 Feb 01; 44(2):781-90. PubMed ID: 12556414
    [Abstract] [Full Text] [Related]

  • 17. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.
    Mori K, Gehlbach P, Ando A, McVey D, Wei L, Campochiaro PA.
    Invest Ophthalmol Vis Sci; 2002 Jul 01; 43(7):2428-34. PubMed ID: 12091447
    [Abstract] [Full Text] [Related]

  • 18. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
    Trattler W, McDonald M.
    Cornea; 2007 Jul 01; 26(6):665-9. PubMed ID: 17592313
    [Abstract] [Full Text] [Related]

  • 19. Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia.
    Lukiw WJ, Ottlecz A, Lambrou G, Grueninger M, Finley J, Thompson HW, Bazan NG.
    Invest Ophthalmol Vis Sci; 2003 Oct 01; 44(10):4163-70. PubMed ID: 14507857
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.